3-Bromopyridine → HCID 23635909, 화합물

HRID 393796

반응식

HRID 393796 반응식
[C@@H:1]12[CH2:7][NH:6][C@@H:5]1[CH2:4][N:3]([C:8]([O:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)=[O:9])[CH2:2]2.Br[C:19]1[CH:20]=[N:21][CH:22]=[CH:23][CH:24]=1>>[N:21]1[CH:22]=[CH:23][CH:24]=[C:19]([N:6]2[CH2:7][C@@H:1]3[C@H:5]2[CH2:4][N:3]([C:8]([O:10][CH2:11][C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)=[O:9])[CH2:2]3)[CH:20]=1

참가 물질

3

반응물 2

HCID 122863-BromopyridineHCID 23635906benzyl (1S,5S)-3,6-diazabicyclo[3.2.0]heptane-3-carboxylate

생성물 1

HCID 23635909HCID 23635909, 화합물수율 61%

실험 절차

The product of Example 52D (230 mg, 1.0 mmol) and 3-bromopyridine were processed according to the procedure described in Example 1E. The crude product was purified by chromatography (SiO2, CH2Cl2:methanol, 95:5, Rf. 0.3) to provide the title compound (190 mg, 61% yield). 1H NMR (MeOH-d4, 300 MHz) δ3.24 (dd, J=12.6, 4.1 Hz, 11H), 3.30 (m, 1H), 3.40 (m, 1H), 3.64 (dd, J=7.8, 3.4 Hz, 1H), 3.92-4.08 (m, 3H), 4.70 (m, 1H), 5.10 (m, 2H), 6.90 (m, 1H), 7.24 (m, 3H), 7.35 (m, 2H), 7.73 (d, J=2.7 Hz, 1H), 7.86 (d, J=4.7 Hz, 1H); MS (DCI/MH3) m/z 310(M+H)+.

후처리

  1. customThe crude product was purified by chromatography (SiO2, CH2Cl2:methanol, 95:5, Rf. 0.3)

출처 및 근거

ORD 기록
ord-441f1365971347df8bb0618e804fe352
출처 데이터셋
uspto-grants-2004_10
특허 번호
US06809105B2

연결된 노트

불러오는 중…